Mitchell Mcleod Pugh & Williams Inc Amgen Inc Transaction History

Mitchell Mcleod Pugh & Williams Inc

  • $473 Million
  • Q4 2024

A detailed history of Mitchell Mcleod Pugh & Williams Inc transactions in Amgen Inc stock. As of the latest transaction made, Mitchell Mcleod Pugh & Williams Inc holds 2,283 shares of AMGN stock, worth $673,621. This represents 0.13% of its overall portfolio holdings.

Number of Shares
2,283
Previous 2,755 17.13%
Holding current value
$673,621
Previous $887,000 32.92%
% of portfolio
0.13%
Previous 0.19%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 16, 2025
SELL
$258.78 - $328.31 $122,144 - $154,962
-472 Reduced 17.13%
2,283 $595,000
Q1 2024

May 01, 2024
BUY
$268.87 - $324.56 $88,995 - $107,429
331 Added 13.66%
2,755 $783,000
Q4 2023

Feb 05, 2024
BUY
$255.7 - $288.46 $45,003 - $50,768
176 Added 7.83%
2,424 $698,000
Q3 2023

Oct 20, 2023
BUY
$218.65 - $271.46 $32,141 - $39,904
147 Added 7.0%
2,248 $604,000
Q2 2023

Aug 08, 2023
SELL
$214.27 - $253.37 $2,785 - $3,293
-13 Reduced 0.61%
2,101 $466,000
Q1 2023

May 10, 2023
SELL
$225.79 - $275.2 $2,935 - $3,577
-13 Reduced 0.61%
2,114 $511,000
Q4 2022

Feb 03, 2023
SELL
$229.03 - $291.01 $916 - $1,164
-4 Reduced 0.19%
2,127 $558,000
Q3 2022

Nov 07, 2022
BUY
$224.46 - $253.15 $6,733 - $7,594
30 Added 1.43%
2,131 $480,000
Q2 2022

Nov 18, 2022
SELL
$230.71 - $256.74 $6,921 - $7,702
-30 Reduced 1.41%
2,101 $511,000
Q2 2022

Jul 19, 2022
BUY
$230.71 - $256.74 $2,999 - $3,337
13 Added 0.62%
2,101 $511,000
Q1 2022

Apr 26, 2022
SELL
$219.27 - $242.57 $3,069 - $3,395
-14 Reduced 0.67%
2,088 $505,000
Q4 2021

Feb 02, 2022
SELL
$198.88 - $227.6 $424,807 - $486,153
-2,136 Reduced 50.4%
2,102 $473,000
Q2 2021

Nov 08, 2021
BUY
$233.58 - $259.14 $6,306 - $6,996
27 Added 0.64%
4,238 $1.03 Million
Q2 2021

Aug 03, 2021
SELL
$233.58 - $259.14 $6,306 - $6,996
-27 Reduced 0.64%
4,211 $1.03 Million
Q1 2021

May 12, 2021
SELL
$221.91 - $258.6 $1,331 - $1,551
-6 Reduced 0.14%
4,238 $1.06 Million
Q2 2020

Jul 17, 2020
SELL
$197.81 - $242.74 $140,840 - $172,830
-712 Reduced 14.37%
4,244 $1 Million
Q2 2019

Jul 09, 2019
SELL
$166.7 - $195.41 $33,340 - $39,082
-200 Reduced 3.88%
4,956 $913,000
Q1 2019

Apr 11, 2019
SELL
$180.87 - $203.88 $1,989 - $2,242
-11 Reduced 0.21%
5,156 $980,000
Q3 2018

Oct 09, 2018
BUY
$185.29 - $208.89 $2,038 - $2,297
11 Added 0.21%
5,167 $1.07 Million
Q1 2018

Apr 16, 2018
SELL
$169.43 - $198.0 $9,149 - $10,692
-54 Reduced 1.04%
5,156 $879,000
Q4 2017

Jan 12, 2018
BUY
$168.79 - $188.59 $9,114 - $10,183
54 Added 1.05%
5,210 $906,000
Q3 2017

Oct 12, 2017
BUY
$167.29 - $191.0 $862,547 - $984,796
5,156
5,156 $961,000

Others Institutions Holding AMGN

# of Institutions
3,118
Shares Held
410M
Call Options Held
8.54M
Put Options Held
7.02M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Mitchell Mcleod Pugh & Williams Inc Portfolio

Follow Mitchell Mcleod Pugh & Williams Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitchell Mcleod Pugh & Williams Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mitchell Mcleod Pugh & Williams Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email